Ọgwụ "Mifegin" ntụziaka dosing

Nkwadebe "Mifegin" na-emepụta n'ụdị mbadamba, na-arụsi ọrụ ike mgwa nke a na-micronised 200 mg mifepristone. Pharmacological sredstovo esịne ke adakarị na pharmacological otu antigestagens ọgwụ enwekwu ụda ma contractility nke muscle mgbidi nke akpanwa.

Nkwadebe "Mifegin" na-ezo aka a sịntetik steroid ọgwụ ọjọọ antigestagens, na-egbochi ihe nke hormone progesterone, enweghị gestagen ọrụ. N'okpuru nduzi nke ọgwụ emee delamination decidua na ọnwụ nke ovum.

Ọgwụ "Mifegin" ntuziaka maka ojiji

The ọgwụ na-kenyere ọgwụ nchupu intrauterine ime ruo 42 ụbọchị; mgbe ọzụzụ na inductions n'oge kwesịrị full-okwu ime.

Ọgwụ "Mifegin" ntụziaka dosing

The ọgwụ na-ndị dọkịta ji mee - ọkachamara na a ọgwụ owuwu.

N'ihi na nchupu nke afọ ime: ọgwụ kenyere ụzọ 600 mg nke micronized mifepristone. 3 Tablet nkwadebe 200 mg kwa ndidi ingests otu ugboro na ọnụnọ nke a dibịa. Mgbe ingestion "Mifegin" nwaanyị ka awa 2 ka a ga-edebe n'okpuru nso nlekọta nke dọkịta.

Iri na asatọ - ụbọchị abụọ mgbe nlekọta "Mifegin" ga-edokwu anya site ultrasound N'ihi ya, na mgbe 8-14 ụbọchị nke re-nyochaa a rụrụ n'ime adakarị na ntọala ma US-akara. Jide n'aka na-ichoputa ịta nke beta-mmadụ chorionic hormone n'ịkwado ime ọpụpụ. Ọ bụrụ na ị nwere ike nweta ihe ndị ha chọrọ N'ihi maka oge nke 14 ụbọchị, mgbe ahụ, na-enwe vakuumaspiratsiya na obligatory amụ aspirate on histology.

Iji kwadebe nnyefe ime contractions razovo mifepristone ndinọ ke ichekwa 200 mg, 1 mbadamba ọma na ọnụnọ nke a dibịa. Mifepristone na-ndinọ ugboro ugboro mgbe awa 24, ọzọ a otu oge 200 mg - 1-ọma mbadamba na ọnụnọ nke a dibịa. Ọ bụrụ na ọrụ adịghị abịa, mgbe 48-72 awa enyocha onodu nke ọmụmụ kanaal, dị ka ọ dị mkpa, inye prostaglandins ma ọ bụ oxytocin.

Ọgwụ "Mifegin" ntụziaka: mmetụta

Women mkpesa nke ala abdominal mgbu, ahụ erughị ala, agbapụta n'ahụ na ọbara si omumu akụkụ. Enweela ihe nkpasu-iwe nke-adịghị ala ala ọrịa nke akpanwa na ya ejiji. Mmetụta nke ọgwụ nwere ike ime adịghị ike, ọgbụgbọ, isi ọwụwa, vomiting, afọ ọsịsa. Nnọọ adịkarịghị e akpọ na ọrịa ịrịba ama nke hyperthermia, urticaria na dizziness.

Mgbe jikọtara ọgwụgwọ na misoprostol mmetụta na-adịkarịghị hụrụ ihe mgbu usoro nke ikpu, ehighi ura, ike ọgwụgwụ, ihe mgbu na ụkwụ, na-ezighị ezi nchegbu, anaemia. Dọkịta mgbe ụfọdụ nwere na-edebe a ọnụ ke haemoglobin na ọbara, na-ada mbà, oke n'ụdị Gịnị.

Ọgwụ "Mifegin" ntụziaka: contraindications

Ọ gaghị ekwe omume nye iwu a ọgwụ:

• na adrenal insufficiency;
• na gbasara akụrụ odida na nnukwu ma ọ bụ ala ala ụdị;
• na hepatic ọdịda nnukwu ma ọ bụ ala ala ụdị;
• porphyria n'oge a nchoputa;
• n'elu-anata a ogologo N'ezie nke glucocorticoids;
• anaemia;
• na-anaghị ekwe nke hemostasis;
• na oké ọrịa, ọrịamkpokọta na ọnọdụ jikọtara extragenital daa ọrịa ;
• bụrụ na nke hypersensitivity ọgwụ ahụ.

Medicine "Mifegin" (mbadamba) ekwesịghị kenyere maka nzube nke ọgwụ na-ete ime na usoro:

• enyo enyo ectopic ime;
• Pregnancy na-adịghị egosi na Clinical ọmụmụ;
• n'oge ime, ebe okwu karịa 42 ụbọchị nke amenorrhea;
• afọ ime, na ensuing na Nchikota na ihe intrauterine ma ọ bụ mgbe a jụrụ ajụ nke mmiri ọgwụ mgbochi afọ;
• na ọrịa nke Genital akụkụ, gbagwojuru anya site mbufụt;
• Ịṅụ Sịga inyom bụ ndị ruru afọ 35 na enwebeghị ọgwụgwọ nyochaa.

Ọgwụ "Mifegin" kwesịghị kenyere maka nzube nke ọzụzụ na itinye n'ọkwa nke oru:

• gestosis oké ụdị, preeclampsia, eclampsia;
• na preterm ma ọ bụ post-okwu ime ;
• Plasenta previa;
• n'oge a ndiiche n'etiti nwa ebu n'afọ na isi na nne pelvis;
• n'okpuru ndiiche nwa ebu n'afọ na ọnọdụ;
• mgbe spotting amaghị etiology.